These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20027982)

  • 1. [Infectious diseases--the progress is huge--a lot remains to be done].
    Dan M
    Harefuah; 2009 Nov; 148(11):775-7. PubMed ID: 20027982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fighting antibiotic resistance].
    Harthug S; Akselsen PE
    Tidsskr Nor Laegeforen; 2008 Oct; 128(20):2343-6. PubMed ID: 19096492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current outlook of infectious diseases in Taiwan.
    Ho M
    J Microbiol Immunol Infect; 1998 Jun; 31(2):73-83. PubMed ID: 10596983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America.
    Spellberg B; Guidos R; Gilbert D; Bradley J; Boucher HW; Scheld WM; Bartlett JG; Edwards J;
    Clin Infect Dis; 2008 Jan; 46(2):155-64. PubMed ID: 18171244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging and re-emerging infections.
    Ranga S; Trivedi N; Khurana SK; Thergaonkar A; Talib VH
    Indian J Pathol Microbiol; 1997 Oct; 40(4):569-81. PubMed ID: 9444876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging and reemerging infections. Progress and challenges in the subspecialty of infectious disease pathology.
    Schwartz DA
    Arch Pathol Lab Med; 1997 Aug; 121(8):776-84. PubMed ID: 9278604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of molecular techniques in the epidemiology and control of infectious diseases.
    Sader HS; Hollis RJ; Pfaller MA
    Clin Lab Med; 1995 Jun; 15(2):407-31. PubMed ID: 7671580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Communicable diseases in Norway. Epidemiological status and future challenge for prevention of the most important diseases].
    Lystad A; Flugsrud LB
    Tidsskr Nor Laegeforen; 1995 Sep; 115(23):2899-903. PubMed ID: 7570514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The worldwide challenges of "new" or reemerging communicable diseases at the dawn of the 21st century].
    Werner GH
    Ann Pharm Fr; 2001 Jul; 59(4):246-77. PubMed ID: 11468579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The worldwide challenges of "new" or reemerging communicable diseases at the dawn of the 21st century].
    Werner GH
    Ann Pharm Fr; 2001 May; 59(3):147-75. PubMed ID: 11427818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leading infectious diseases problems in Turkey.
    Erdem H; Akova M
    Clin Microbiol Infect; 2012 Nov; 18(11):1056-67. PubMed ID: 23043613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance and control of infectious diseases: progress toward the 1990 objectives.
    Dowdle WR
    Public Health Rep; 1983; 98(3):210-8. PubMed ID: 6867252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chapter 5.9: major public health problems - infectious disease.
    Carlson J
    Scand J Public Health Suppl; 2006 Jun; 67():132-8. PubMed ID: 16762906
    [No Abstract]   [Full Text] [Related]  

  • 14. Emerging infectious disease: global response, global alert.
    Nakajima H
    Health Millions; 1997; 23(2):19. PubMed ID: 12348002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drivers for the emergence and re-emergence of vector-borne protozoal and bacterial diseases.
    Harrus S; Baneth G
    Int J Parasitol; 2005 Oct; 35(11-12):1309-18. PubMed ID: 16126213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging infectious diseases in Alaska and the Arctic: a review and a strategy for the 21st century.
    Butler JC; Parkinson AJ; Funk E; Beller M; Hayes G; Hughes JM
    Alaska Med; 1999; 41(2):35-43. PubMed ID: 10434444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conclusion: ESCMID declaration on meeting the challenges in clinical microbiology and infectious diseases.
    Struelens MJ; Van Eldere J
    Clin Microbiol Infect; 2005 Apr; 11 Suppl 1():50-1. PubMed ID: 15760445
    [No Abstract]   [Full Text] [Related]  

  • 18. [Agents and consequences of nosocomial infections in a Lebanese university hospital. Retrospective study over a two-year period].
    Tohmé A; Karam-Sarkis D; El-Rassi R; Chélala D; Ghayad E
    Ann Med Interne (Paris); 2001 Mar; 152(2):77-83. PubMed ID: 11357042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of infections caused by drug-resistant organisms in critical care.
    Hoppe B
    Am J Crit Care; 1997 Mar; 6(2):141-4. PubMed ID: 9172851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Global strategies in prevention of infectious diseases on the turn of the second and third millennium: expectation versus reality].
    Juszczyk J
    Przegl Epidemiol; 2004; 58 Suppl 1():5-9. PubMed ID: 15807151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.